Possible immunomodulatory role of Filifactor alocis through beta-defensin 2 in gingival keratinocytes
- PMID: 39592494
- DOI: 10.1007/s00784-024-06043-0
Possible immunomodulatory role of Filifactor alocis through beta-defensin 2 in gingival keratinocytes
Abstract
Objectives: The present study aimed to investigate a possible immunomodulatory role of the periodontopathogen Filifactor alocis through the antimicrobial peptide hBD-2 on the expression of chemokines in human gingival keratinocytes.
Materials and methods: Cells were cultured in the presence or absence of periodontopathogenic bacteria, such as F. alocis, Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Treponema denticola, to evaluate the regulation of hBD-2, CXCL8 and CCL20. Furthermore, the cells were exposed or not to hBD-2 and the expression of CXCL8 and CCL20 and their receptors was evaluated.
Results: All bacteria induced a significant upregulation of hBD-2, CXCL8, and CCL20 gene expressions. In addition, F. alocis significantly increased their protein levels, as detected by ELISA. Pre-incubation of the cells with the TLR2 inhibitor resulted in a significant downregulation of hBD-2 expression in F. alocis-treated cells. Gingival keratinocytes exposed to hBD-2 resulted in a significant and dose-dependent increase of all chemokines and their receptors.
Conclusions: F. alocis increased the production of chemotactic cytokines, suggesting an increase in the recruitment of immunoinflammatory cells in periodontal diseases. The chemotaxis-promoting effect is partly direct, but is also mediated via hBD-2. F. alocis stimulates the synthesis of hBD-2, which in turn could promote the expression and synthesis of these chemokines and their receptors. In addition, hBD-2 has an autostimulatory effect and stimulates the synthesis of these chemokines, so that the chemotaxis triggered by F. alocis is further fueled.
Clinical relevance: F. alocis and hBD-2 have a significant role in periodontitis, showing their importance for diagnostic and treatment approaches.
Keywords: Beta-defensins; Epithelial cells; Immune response; Inflammation; Periodontitis.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: Not applicable. Informed consent: Not applicable. Cell line: hTERT TIGKs RRID: CVCL_M095. Competing interests: The authors declare no competing interests.
References
-
- Deng ZL, Szafrański SP, Jarek M, Bhuju S, Wagner-Döbler I (2017) Dysbiosis in chronic periodontitis: key microbial players and interactions with the human host. Sci Rep 7:3703. https://doi.org/10.1038/s41598-017-03804-8 - DOI - PubMed - PMC
-
- Lamont RJ, Koo H, Hajishengallis G (2018) The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol 16:745–759. https://doi.org/10.1038/s41579-018-0089-x - DOI - PubMed - PMC
-
- Golub LM, Lee HM (2020) Periodontal therapeutics: Current host-modulation agents and future directions. Periodontol 2000 82:186–204. https://doi.org/10.1111/prd.12315
-
- Diamond DL, Kimball JR, Krisanaprakornkit S, Ganz T, Dale BA (2001) Detection of beta-defensins secreted by human oral epithelial cells. J Immunol Methods 256:65–76. https://doi.org/10.1016/s0022-1759(01)00442-2 - DOI - PubMed
-
- Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710–720. https://doi.org/10.1038/nri1180 - DOI - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
